# Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy

> **NCT05933434** · PHASE1,PHASE2 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** Allogenic adipose derived mesenchymal stem cells (AD-MSC)
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05933434
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-07
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05933434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05933434, "Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05933434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*